By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Serono International S.A. 

15 bis, Chemin des Mines
Case postale 54
Geneva 20    CH-1211  Switzerland
Phone: 41-22-739-3000 Fax: 41-22-731-2179



Company News
Merck KGaA (MKGAF.PK) Acquires Majority Shareholding In Serono S.A. 1/8/2007 2:19:52 PM
Merck Serono Is Launched; Top Management Appointed; Integration Process Begins; Erbitux (R) Production Consolidated In Switzerland 1/8/2007 11:51:49 AM
ZymoGenetics, Inc. (ZGEN) And Serono Begin Phase 2 Clinical Trial With Atacicept In Rheumatoid Arthritis 12/20/2006 3:15:04 PM
Merck KGaA (MKGAF.PK) Release: European Antitrust Authorities Clear Acquisition Of Serono International S.A. (SRA) 12/18/2006 1:36:40 PM
Serono International S.A. (SRA) Announces Initiation Of The Reflex Trial To Evaluate New Formulation Of Rebif(R) In Patients At Risk Of Developing Multiple Sclerosis 12/12/2006 1:15:10 PM
Micromet Receives $10 Million Milestone Payment From Serono, Inc. (SRA) For Completion Of Phase 2 Clinical Trials 12/4/2006 11:37:36 AM
ZymoGenetics, Inc. (ZGEN) And Serono International S.A. (SRA) Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial In Patients With Lupus 11/13/2006 11:42:50 AM
Serono International S.A. (SRA) Delivers Strong Adjusted Net Income Of $183.5m In Third Quarter 2006 10/19/2006 10:38:04 AM
The Day In Review: Amgen (AMGN) Gets Approvable Letter 10/16/2006 6:05:27 PM
Serono International S.A. (SRA) Says Cancer Drug Fails To Meet Goals 10/2/2006 9:14:19 AM